Here are relevant reports on : meal-kits-market
-
Smart Shopping Cart Market by Cart Type (Fully Integrated Carts, Retrofit Kits), Application Area (Shopping Malls, Supermarkets), Mode of Sale (Direct, Distributor) - Global Forecast to 2030
The smart shopping cart market is expected to grow from USD 326.0 million in 2025 to USD 1,423.1 million by 2030, at a CAGR of 34.3% during the forecast period. The report profiles key players, such as Amazon (US), Caper (US), Veeve (US), Shopic (Israel), SuperHii (China), Tracxpoint (Israel), Cust2Mate (Israel), Shekel (Israel), Faytech (US), KBST (Germany), MetroClick (US), Retail AI (Japan), Pentland Firth Software (Germany), VasyERP (India), Smapca (India), SwiftForce (India), Kwikkart (US), ZeroQs (Poland), Shopreme (Austria), and Trollee (Hong Kong).
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030
The global veterinary biologics market, valued at US$2.61 billion in 2024, stood at US$2.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2030, culminating in a forecasted valuation of US$3.51 billion by the end of the period. The market growth is fueled by increasing demand for effective animal therapeutics, rising populations of livestock and companion animals, and greater awareness of animal health and disease prevention.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
North America Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology]-Forecast to 2030
The North America epigenetics market, valued at USD 0.84 billion in 2024, stood at USD 0.93 billion in 2025 and is projected to advance at a resilient CAGR of 13.8% from 2025 to 2030, culminating in a forecasted valuation of USD 1.78 billion by the end of the period. Growth of the North America epigenetics market is driven by a strong, well-funded life sciences ecosystem, with rising oncology and precision-medicine programs that rely on methylation and chromatin profiling.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030
The global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) & Region - Global Forecast to 2028
The global transfection technologies market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 9.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.8 billion by the end of the period. The growth of this market is largely driven by the increased R&D investments and growing need of cell-based therapies. Furthermore, increased research activities for drug discovery and development, the transfection technologies have seen substantial expansion over the last decade.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Epigenetics Market by Product & Service (Enzymes, Kits & Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User - Global Forecast to 2030
The global epigenetics market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 11.3% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period. The major factors driving the growth in epigenetics market includes reduced sequencing costs and accelerated turnaround times to improve access and affordability of epigenetic analysis.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Western Blot), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Laboratories) - Global Forecast to 2030
The global immunoassay market, valued at US$34.4 billion in 2024, stood at US$35.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$47.7 billion by the end of the period. This growth is primarily driven by the increasing prevalence of chronic and infectious diseases worldwide, which has boosted the demand for early and accurate diagnostic solutions.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028
The global base editing market, valued at US$260 million in 2022, stood at US$270 million in 2023 and is projected to advance at a resilient CAGR of 15.2% from 2023 to 2028, culminating in a forecasted valuation of US$549 million by the end of the period.The growth of the base editing market is largely driven by the rising prevalence of genetic diseases, and the increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030
The global exosome research market, valued at US$189.4 million in 2024, stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a forecasted valuation of US$480.6 million by the end of the period. The growth of the Asia Pacific exosome research market is primarily due to the growing biomedical industry, increasing life science research, and rising investments by pharmaceutical & biotechnology companies in this region.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
